300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Sports
Legal
eSports
Construction
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Cannabis
Fashion
LGBT
Social
Celebrity
Beauty
Infrastructure
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Oman
Africa
Oceania
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Australia
Uzbekistan
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
Canada
France
Georgia
United Kingdom
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Philippines
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Angola
Europe
Belgium
Cyprus
Barbados
Jordan
Austria
Ethiopia
Qatar
Azerbaijan
Bulgaria
Bahamas
Ecuador
Faroe Islands
Estonia
Bolivia
Algeria
Belize
Finland
Jersey
Italy
Bahrain
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Honduras
Lithuania
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Federica Di Palma, Chief Scientific Officer and Vice President Sectors at Genome British Columbia

Federica Di Palma

Chief Scientific Officer and Vice President Sectors @ Genome British Columbia

Federica Di Palma is a grant investor at Genome British Columbia focused on Medical and Biotechnology. Federica Di Palma

Total investments:
1
Last investment:
Lead investor:
100%

Last updated:

Industries Federica Di Palma invests in

MedicalBiotechnology

Stages Federica Di Palma invests in

Grant

Countries Federica Di Palma invests in

Canada

Investment Focus

Industry

  • Medical 1 (100%)
  • Biotechnology 1 (100%)

Investments

CompanyDescriptionRoundLinks
Avivo Biomedical Avivo Biomedical
Avivo Biomedical operates as a preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type. $250K / Grant / Mar 31, 2022
Genome British Columbia

About Genome British Columbia

VC Fund · Vancouver, Canada

Genome BC, a non-profit research organization, leads genomics innovation on Canada’s West Coast and facilitates the integration of genomics into society. Their major investors are the Province of British Columbia and the Government of Canada through Genome Canada and Western Economic Diversification Canada. This funding is complemented bypartnerships with many national and international public and private funding organizations to drive BC’s bioeconomy.

Genome British Columbia Contacts

NameEmailPhoneSocials
Tony Brooks CFO& VP Entrepreneurship & Commercialization
Catalina Lopez-Correa
Catalina Lopez-Correa Chief Scientific Officer & Vice President Sectors
Federica Di Palma
Federica Di Palma Chief Scientific Officer and Vice President Sectors

Sign up to unlock verified contacts

Unlock Contacts

2 more contacts available

Open Genome British Columbia full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Sports
Legal
eSports
Construction
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Cannabis
Fashion
LGBT
Social
Celebrity
Beauty
Infrastructure
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Oman
Africa
Oceania
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Australia
Uzbekistan
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
Canada
France
Georgia
United Kingdom
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Philippines
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Angola
Europe
Belgium
Cyprus
Barbados
Jordan
Austria
Ethiopia
Qatar
Azerbaijan
Bulgaria
Bahamas
Ecuador
Faroe Islands
Estonia
Bolivia
Algeria
Belize
Finland
Jersey
Italy
Bahrain
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Honduras
Lithuania
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Federica Di Palma invest in?

Federica Di Palma invests primarily in Medical and Biotechnology startups, most often at Grant stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Federica Di Palma last invest?

The most recent investment recorded for Federica Di Palma closed in Mar 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Federica Di Palma Federica Di Palma Find email